- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-4-4-mer
- Ligands
- 4 x ZN: ZINC ION(Non-covalent)
- 8 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)
ATP.2: 11 residues within 4Å:- Chain A: K.4166, K.4169, M.4884, E.4885, K.4887, C.4888, F.4889, I.4890, T.4909, H.4913, L.4915
9 PLIP interactions:9 interactions with chain A- Hydrogen bonds: A:F.4889, A:I.4890, A:T.4909, A:H.4913, A:L.4915
- Salt bridges: A:K.4166, A:K.4169, A:K.4169, A:K.4881
ATP.4: 9 residues within 4Å:- Chain A: C.917, E.928, Y.931, W.1007, R.1011, W.1016, Q.1022, N.1029, R.1031
6 PLIP interactions:6 interactions with chain A- Hydrogen bonds: A:W.1007, A:Q.1022, A:Q.1022
- Salt bridges: A:R.1011, A:R.1031, A:R.1031
ATP.6: 11 residues within 4Å:- Chain F: K.4166, K.4169, M.4884, E.4885, K.4887, C.4888, F.4889, I.4890, T.4909, H.4913, L.4915
9 PLIP interactions:9 interactions with chain F- Hydrogen bonds: F:F.4889, F:I.4890, F:T.4909, F:H.4913, F:L.4915
- Salt bridges: F:K.4166, F:K.4169, F:K.4169, F:K.4881
ATP.8: 9 residues within 4Å:- Chain F: C.917, E.928, Y.931, W.1007, R.1011, W.1016, Q.1022, N.1029, R.1031
6 PLIP interactions:6 interactions with chain F- Hydrogen bonds: F:W.1007, F:Q.1022, F:Q.1022
- Salt bridges: F:R.1011, F:R.1031, F:R.1031
ATP.10: 11 residues within 4Å:- Chain G: K.4166, K.4169, M.4884, E.4885, K.4887, C.4888, F.4889, I.4890, T.4909, H.4913, L.4915
9 PLIP interactions:9 interactions with chain G- Hydrogen bonds: G:F.4889, G:I.4890, G:T.4909, G:H.4913, G:L.4915
- Salt bridges: G:K.4166, G:K.4169, G:K.4169, G:K.4881
ATP.12: 9 residues within 4Å:- Chain G: C.917, E.928, Y.931, W.1007, R.1011, W.1016, Q.1022, N.1029, R.1031
6 PLIP interactions:6 interactions with chain G- Hydrogen bonds: G:W.1007, G:Q.1022, G:Q.1022
- Salt bridges: G:R.1011, G:R.1031, G:R.1031
ATP.14: 11 residues within 4Å:- Chain H: K.4166, K.4169, M.4884, E.4885, K.4887, C.4888, F.4889, I.4890, T.4909, H.4913, L.4915
9 PLIP interactions:9 interactions with chain H- Hydrogen bonds: H:F.4889, H:I.4890, H:T.4909, H:H.4913, H:L.4915
- Salt bridges: H:K.4166, H:K.4169, H:K.4169, H:K.4881
ATP.16: 9 residues within 4Å:- Chain H: C.917, E.928, Y.931, W.1007, R.1011, W.1016, Q.1022, N.1029, R.1031
6 PLIP interactions:6 interactions with chain H- Hydrogen bonds: H:W.1007, H:Q.1022, H:Q.1022
- Salt bridges: H:R.1011, H:R.1031, H:R.1031
- 4 x CA: CALCIUM ION(Non-covalent)
CA.3: 3 residues within 4Å:- Chain A: E.3848, E.3922, T.4931
3 PLIP interactions:3 interactions with chain A- Metal complexes: A:E.3848, A:E.3922, A:T.4931
CA.7: 3 residues within 4Å:- Chain F: E.3848, E.3922, T.4931
3 PLIP interactions:3 interactions with chain F- Metal complexes: F:E.3848, F:E.3922, F:T.4931
CA.11: 3 residues within 4Å:- Chain G: E.3848, E.3922, T.4931
3 PLIP interactions:3 interactions with chain G- Metal complexes: G:E.3848, G:E.3922, G:T.4931
CA.15: 3 residues within 4Å:- Chain H: E.3848, E.3922, T.4931
3 PLIP interactions:3 interactions with chain H- Metal complexes: H:E.3848, H:E.3922, H:T.4931
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Miotto, M.C. et al., Structural basis for ryanodine receptor type 2 leak in heart failure and arrhythmogenic disorders. Nat Commun (2024)
- Release Date
- 2023-11-22
- Peptides
- Ryanodine receptor 2: AFGH
Peptidyl-prolyl cis-trans isomerase FKBP1B: BCDE - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AF
BG
CH
DB
EC
FD
GE
H
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-4-4-mer
- Ligands
- 4 x ZN: ZINC ION(Non-covalent)
- 8 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)
- 4 x CA: CALCIUM ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Miotto, M.C. et al., Structural basis for ryanodine receptor type 2 leak in heart failure and arrhythmogenic disorders. Nat Commun (2024)
- Release Date
- 2023-11-22
- Peptides
- Ryanodine receptor 2: AFGH
Peptidyl-prolyl cis-trans isomerase FKBP1B: BCDE - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AF
BG
CH
DB
EC
FD
GE
H